News & Events
November 27, 2017
Soundbite November 2017

Welcome to the latest Soundbite. This month, you’ll find out about a new drug that protects your hearing after cancer treatment, read the latest research into age-related hearing loss ­– and discover how you can help shape the future of hyperacusis research.

RESEARCH AND TECHNOLOGY NEWS

Hyperacusis research – have your say

Hyperacusis researchers in Nottingham

Do you experience hyperacusis or support someone who does? Researchers in Nottingham want to make sure they’re asking the questions that count. Help them by sharing your opinions and experiences in their online survey by Friday 5th January 2018.

TAKE THE SURVEY

 

New drug protects hearing after cancer

Child with hearing loss

Some cancer survivors develop hearing loss, caused by the drugs that treated their cancer. Now, a US-based company, Fennec Pharmaceuticals, has developed a new drug that prevents this happening to children who’ve been treated for liver cancer.

FIND OUT MORE

 

Understanding age-related hearing loss

Dr Laura Corns

Our hearing does deteriorate with age. The more we understand what happens to the cells in our ears, the likelier we are to prevent and treat this type of hearing loss. Dr Laura Corns, our new Pauline Ashley Fellow, tells us about her cutting-edge research in her blog.

READ BLOG

 

 

In the 2017 edition of Hearing Progress, you can read, in depth, about the progress that Action on Hearing Loss have made in accelerating the development of technology and treatments to help people confronting deafness, tinnitus and hearing loss.

Download report
Share: